Skip to main content
logo
Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.405
-0.005 (-0.11%)
Nov 28, 2025, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Novel Therapeutics
6.17M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-65.98%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
United States
6.17M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-65.98%
Log In
Log In
Log In
Log In
Upgrade